|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.348
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.299
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.293
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.258
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.174
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.168
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.164
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.164
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.153
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.153
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.152
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.145
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.140
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.140
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.137
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.134
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.128
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.125
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.124
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.124
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.122
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.110
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.107
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.104
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.101
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.096
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.096
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.095
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.093
|
|
|
|
positive regulation of posttranscriptional gene silencing
|
GO:0060148 |
1 |
0.090
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.089
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.085
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.083
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.083
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.082
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.082
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.080
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.077
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.077
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.076
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.074
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.073
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.073
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.073
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.069
|
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.067
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.065
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.064
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.063
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.063
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.062
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.059
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.059
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.058
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.058
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.057
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.057
|
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.057
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.056
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.055
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.055
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.055
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.055
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.055
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.054
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.054
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.054
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.053
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.053
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.053
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.052
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.051
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.050
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.050
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.049
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.049
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.049
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.048
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.048
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.047
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.047
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.046
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.046
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.046
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.045
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.045
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.045
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.044
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.044
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.043
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.043
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.043
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.043
|
|
|
|
actin modification
|
GO:0030047 |
1 |
0.043
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.043
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.042
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.042
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.042
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.042
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.042
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.042
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.041
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.041
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.041
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.041
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.041
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.040
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.040
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.040
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.040
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.040
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.040
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.039
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.039
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.039
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.039
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.038
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.038
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.037
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.037
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.036
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.036
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.036
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.036
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.036
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.036
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.035
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.035
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.035
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.034
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.034
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.034
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.034
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.034
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.034
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.034
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.033
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.033
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.033
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.033
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.032
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.032
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.032
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.032
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.031
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.031
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.031
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.030
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.030
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.030
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.030
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.030
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.029
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.029
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.029
|
|
|
|
collagen catabolic process
|
GO:0030574 |
6 |
0.029
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.029
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.029
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.029
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.029
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.029
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.029
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.028
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.028
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.028
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.027
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.027
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.027
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.027
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.027
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.027
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.027
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.026
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.026
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.026
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.025
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.025
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.025
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.025
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.025
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.025
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.025
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.025
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.025
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.024
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.024
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.024
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.024
|
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.024
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.024
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.024
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.024
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.024
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.024
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.024
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.023
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.023
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.023
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.023
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.023
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.023
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.023
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.022
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.022
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.022
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.022
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.022
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.022
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
30 |
0.022
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.021
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.021
|
|
|
|
peptidyl proline modification
|
GO:0018208 |
6 |
0.021
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.021
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.021
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.021
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.021
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.021
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.021
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.021
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.021
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.021
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.021
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.020
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.020
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.020
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.020
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.020
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.020
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.020
|
|
|
|
chemorepulsion of branchiomotor axon
|
GO:0021793 |
1 |
0.020
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.020
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.019
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.019
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.019
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.019
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.019
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.019
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.019
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.019
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.019
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.019
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.019
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.018
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.018
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.018
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.018
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.018
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.017
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.017
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.017
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.017
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.017
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.017
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.017
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.017
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.017
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.017
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.017
|
|
|
|
mesenchymal stem cell proliferation
|
GO:0097168 |
1 |
0.017
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.017
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.017
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.017
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.016
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.016
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.016
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.016
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.016
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.016
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.016
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.016
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.016
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.016
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.016
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.016
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.016
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.016
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.016
|
|
|
|
regulation of oxidative stress induced cell death
|
GO:1903201 |
14 |
0.016
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.015
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.015
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.015
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.015
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.015
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
wound healing spreading of cells
|
GO:0044319 |
8 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.015
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.015
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.015
|
|
|
|
negative regulation of hepatocyte differentiation
|
GO:0070367 |
1 |
0.015
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.015
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.015
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.015
|
|
|
|
negative regulation of chemotaxis
|
GO:0050922 |
11 |
0.015
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.015
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.015
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.015
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.014
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.014
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.014
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.014
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.014
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.014
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.014
|
|
|
|
inner ear receptor cell development
|
GO:0060119 |
39 |
0.014
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.014
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.014
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.014
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.014
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.014
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.014
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.014
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.014
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.014
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.013
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.013
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.013
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.013
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.013
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.013
|
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.013
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.013
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.013
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.013
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.013
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.013
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.013
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.013
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.013
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.013
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.013
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.013
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.012
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.012
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.012
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.012
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.012
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.012
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.012
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.012
|
|
|
|
fasciculation of sensory neuron axon
|
GO:0097155 |
3 |
0.012
|
|
|
|
epiboly
|
GO:0090504 |
8 |
0.012
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.012
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.012
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.012
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.012
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.012
|
|
|
|
mirna metabolic process
|
GO:0010586 |
10 |
0.012
|
|
|
|
cellular hyperosmotic salinity response
|
GO:0071475 |
0 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.012
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.012
|
|
|
|
skeletal muscle satellite cell differentiation
|
GO:0014816 |
6 |
0.012
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.012
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.012
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.012
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.012
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
luteinization
|
GO:0001553 |
8 |
0.012
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.012
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.012
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.012
|
|
|
|
protein localization to cell surface
|
GO:0034394 |
10 |
0.012
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.012
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.012
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.012
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.012
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.012
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.012
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.011
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.011
|
|
|
|
regulation of gene silencing by rna
|
GO:0060966 |
5 |
0.011
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.011
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.011
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.011
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.011
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.011
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.011
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.011
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.011
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.011
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.011
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.011
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.011
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.011
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.011
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.011
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.011
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.011
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.011
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.011
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.011
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.011
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.011
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.011
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.011
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
3 |
0.011
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.011
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.011
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
24 |
0.011
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.011
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.011
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
|
positive regulation of dna biosynthetic process
|
GO:2000573 |
4 |
0.011
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.011
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.011
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.011
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.010
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.010
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.010
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.010
|
|
|
|
actin ubiquitination
|
GO:0007014 |
1 |
0.010
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.010
|
|
|
|
cerebellum vasculature development
|
GO:0061300 |
1 |
0.010
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.010
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.010
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.010
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.010
|
|
|
|
muscular septum morphogenesis
|
GO:0003150 |
4 |
0.010
|
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
3 |
0.010
|
|
|
|
learning
|
GO:0007612 |
98 |
0.010
|
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.010
|
|
